parvaquone has been researched along with Equine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehlhorn, H; Schein, E | 1 |
| Gipson, CA; Kuttler, KL; Zaugg, JL | 1 |
2 other study(ies) available for parvaquone and Equine Diseases
| Article | Year |
|---|---|
Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998.
Topics: Animals; Antiprotozoal Agents; Arachnid Vectors; Babesia; Erythrocytes; Horse Diseases; Horses; Life Cycle Stages; Lymphocytes; Naphthoquinones; Piperidines; Quinazolines; Quinazolinones; Theileria; Theileriasis; Ticks | 1998 |
Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids.
Topics: Animals; Antiprotozoal Agents; Babesiosis; Carbanilides; Horse Diseases; Horses; Imidocarb; Injections, Intramuscular; Male; Naphthoquinones; Splenectomy | 1987 |